Yaz Related to Blood Clots as Company Begins Settling Lawsuits

Share Article

The Web’s largest source for information on Yaz legal news, side effects and research can be found at the Yaz Resource Center. Visit http://www.YazLawsuit.com

yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

The Yaz Resource Center, a patient advocacy group, is alerting women prescribed the birth control Yaz or Yasmin that experts have associated the drugs with dangerous blood clot injuries. Also, the maker of these drugs has reserved millions to settle claims by those injured. However, the time to file may be limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

On October 25, 2011, the British Medical Journal published a University of Copenhagen study which linked the hormone in Yaz to blood clots. The FDA followed on October 27, 2011 with its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA.

Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates that more than 11,000 patients have filed a claim.

According to a Bloomberg News article on July 31st, Bayer has begun settling Yaz lawsuits, with as many as 1900 resolved so far. The company has reserved up to $610 million to dispense the cases at an average of around $212,000.

The Yaz settlement news is positive for those injured who have yet to file a claim. Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible.

The Yaz Resource Center cautions that victims should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects of yaz and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website